Side effects associated with Brevital Sodium are extensions of pharmacologic effects and include:
Circulatory depression, thrombophlebitis, hypotension, tachycardia, peripheral vascular collapse, and convulsions in association with cardiorespiratory arrest
Respiratory depression (including apnea), cardiorespiratory arrest, laryngospasm, bronchospasm, hiccups, and dyspnea
Skeletal muscle hyperactivity (twitching), injury to nerves adjacent to injection site, and seizures
Emergence delirium, restlessness, and anxiety may occur, especially in the presence of postoperative pain
Nausea, emesis, abdominal pain, and liver function tests abnormal
Erythema, pruritus, urticaria, and cases of anaphylaxis have been reported rarely
Other adverse reactions include pain at injection site, salivation, headache, and rhinitis
For medical advice about adverse reactions contact your medical professional. To report SUSPECTED ADVERSE REACTIONS, contact JHP at 1-866-923-2547 or MEDWATCH at 1800-FDA-1088 (1-800-332-1088) or http://www.fda.gov/medwatch/.
Drug Abuse And Dependence
Controlled Substance-Brevital Sodium is a Schedule IV drug.
Brevital Sodium may be habit-forming.